ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Rheumatology Oxford University Press

Book Volume: 58

DOI: 10.1093/rheumatology/kez107.088

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Universitat de Barcelona (UB) / University of Barcelona

Spain (ES) Hospital for Special Surgery (HSS)

United States (USA) (US) Harvard University

United States (USA) (US) Genentech Inc.

United States (USA) (US) Southend Hospital

United Kingdom (GB) Technische Universität Dresden

Germany (DE) Roche Products Limited and Roche Diagnostics Limited

United Kingdom (GB) University of Groningen / Rijksuniversiteit Groningen

Netherlands (NL) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Belgium (BE) Arcispedale Santa Maria Nuova

Italy (IT) Ludwig-Maximilians-Universität (LMU)

Germany (DE)

How to cite

APA:

Stone, J.H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D.,... Collinson, N. (2019). ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL.

MLA:

Stone, John H., et al. "ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL." 2019.

BibTeX: Download